Cannabis Law Report

FEBRUARY 2, 2022

In addition to his support of advocacy for regenerative organic agriculture, David directs Dr. Bronner’s resources to support animal advocacy, wage equality, and drug policy reform. Los’s mission in life is to impact the planet as an advocate for natural medicine. Julia Mirer. Kelly Bender. Patrick Moher.

Medicine 52

Medicine Advocacy Microdosing Agriculture 52

Cannabis Law Report

MARCH 12, 2022

The workgroup will include a member of the Psychedelic Medicine Alliance of Washington as well as other community, health care, and regulatory representatives. Washington legislators fund $200,000 USD for a Psilocybin Wellness Workgroup to research and write a report that will inform a pathway for future legislation. ?

Medicine 52

Medicine Advocacy Legislation Treatment 52

Cannabis Law Report

NOVEMBER 15, 2021

Plant medicine use has long shaped and informed American Indian cultural, clan and familial identity. Today plant medicines like peyote, datura and others continue to play an important role within many tribal communities as they struggle to overcome the legacy of European conquest and colonization.

Medicine 52

Medicine Advocacy Research and Development Therapy 52

Veriheal

SEPTEMBER 18, 2020

That very situation presented itself in Indonesia earlier this year, as cannabis was first declared a medicinal plant, then quickly revised to remain an illegal substance. This decree listed cannabis, along with 65 other plants, as “medicinal.” Indonesia’s Initial Declaration. The Decree Will Be Revised .

Medicine 52

Medicine Agriculture Advocacy Cannabis 52

Veriheal

FEBRUARY 8, 2024

All-star basketball player Kevin Durant recently scored a historic victory for cannabis advocacy. In recent years, other major US sports leagues, including the National Football League (NFL), National Hockey League (NHL), and Major League Baseball (MLB), have taken significant steps for cannabis advocacy and normalization.

Advocacy 113

Advocacy Chronic Pain Policy Cannabis 113

Cannabis Law Report

AUGUST 19, 2021

Canada’s Cannabis License Holders are broadly distributed across Canada, representing the sector’s untold advocacy strength” said George Smitherman, President and CEO of the Cannabis Council of Canada (C3). Election advocacy training sessions open to all Health Canada License Holders.

Advocacy 105

Advocacy Research and Development Cannabis Environment 105

Cannabis Law Report

JANUARY 23, 2020

Each of the advisory board members brings a unique perspective that will be crucial in helping inform and guide the CPG industry’s advocacy approach on this rapidly evolving issue.”. Michael Taylor, former deputy commissioner for foods and veterinary medicine, U.S. Food and Drug Administration. “I

Advocacy 59

Advocacy CBD Food Safety 59

Cannabis Law Report

OCTOBER 2, 2022

Cannabiz Australia The fourth annual Australian Cannabis Summit will be held on October 28-29, with a spotlight on breaking the stigma surrounding medicinal cannabis consumption. The first […].

Advocacy 52

Advocacy Consumption Legislation Cultivation 52

Cannabis Law Report

FEBRUARY 3, 2022

The Humboldt County Growers Alliance, a trade association that represents 275 licensed cannabis businesses in Humboldt County, recently joined the Origins Council as a regional partner for state and federal cannabis advocacy.

Law 97

Law Supply Chain Advocacy Compliance 97

Cannabis Law Report

AUGUST 8, 2021

Advocacy group TheraPsil is teaming up with lawyers to pressure the government to grant access and develop regulations. More than ever, Canadians want to use psychedelics as medicine to relieve severe mental distress, but after a promising stretch of granted exemptions, regulator Health Canada appears to be stalling the process.

Access 105

Access Patients Legalization Advocacy 105

NORML

OCTOBER 2, 2019

However, this time, they’ve taken their advocacy to our nation’s capital for NORML’s National Conference to lobby for reform on the federal level and expanded access to medicinal cannabis, such as The MORE Act and the Veterans Affairs Medicinal Cannabis Research Act of 2019.

Advocacy 189

Advocacy Legislation Collective Access 189

NORML

FEBRUARY 26, 2019

While most of the recent media conversation around cannabis and the Super Bowl surrounded the ability for a medical marijuana company’s attempt to air an advertisement, one of the issues raised by various NORML members over the last few weeks has been more focused on the actual well-being of the players themselves.

Access 200

Access Medicine Policy Media 200

The Cannigma

JULY 17, 2022

What started as providing information quickly grew into a network of organization, advocacy, research, and education. . Realm of Caring serves to fill this gap; to prove cannabis can serve as a legitimate medicine through our Observational Research Registry with Johns Hopkins University.”. All of this research and advocacy adds up.

Advocacy 120

Advocacy Education Events Epilepsy 120

NORML

JANUARY 7, 2020

Over the course of twelve months, the proud fighters of the Las Vegas chapter have taken cannabis advocacy, education and community to otherworldly levels through a variety of far-reaching ways. Tina showed the true power of Nevada NORML’s advocacy on a national level. Organized a virtual lobbying mission on Veterans’ Day.

Advocacy 130

Advocacy Legislation Patients Media 130

NORML

MAY 12, 2020

By the time she learned she was breaking the law, cannabis medicine was saving her life. Through her advocacy work, Tamara met more and more people who had been arrested for cannabis, and it troubled her how important pieces of those stories were left out of the news coverage the general public sees.

Advocacy 277

Advocacy Legislation Chronic Pain Education 277

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. “We hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Cannabis Law Report

JULY 25, 2022

Psychedelics, medicine and ethics has always been a tricky thing and we’re suprised (or maybe not) that those who have held themselves up to be the paragons of perfection in the field over the past few years, have in fact been either arrogant, dumb or lazy when it comes to managing ethics at their organisations.

Medicine 52

Medicine Therapy Research and Development Business 52

Medicinal Marijuana Association

FEBRUARY 12, 2024

Start by defining the purpose of your event, whether it’s educational, recreational, or advocacy-focused. Collect feedback from participants to improve future events and build a stronger community around cannabis education and advocacy. Choose a suitable venue that aligns with the tone and goals of your event.

Advocacy 52

Advocacy Education Events Environment 52

Cannabis Law Report

JUNE 12, 2021

Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. methadone) demonstrate a feasible alternative approach.

Policy 66

Policy Safety Medicine Access 66

Americans for Safe Access

JUNE 6, 2018

The air was filled with excitement that the ECDD was finally beginning the process of looking at new information regarding cannabis as medicine. A process that has been long overdue considering the original scheduling of cannabis was created based on a report produced by the Health Committee of the League of Nations back in 1935.

Advocacy 100

Advocacy Medicine Cannabis Patients 100

Veriheal

MARCH 2, 2024

In the past, drugs containing substances from certain parts of the cannabis plant were permitted only for clinical trials in Japan, but Japanese patient advocacy groups have been pushing for access to cannabis-derived CBD medicines that are evidenced to provide valuable treatment for various disorders.

Legalization 108

Legalization Epilepsy Clinical Trials THC 108

Cannabis Law Report

APRIL 12, 2022

More than 40 countries have legalised consumption of cannabis for medicinal purposes. The caucus believes that Malaysia has the space and a huge opportunity in this industry for medicinal and research purposes which could deliver a lot of benefits for the country,” the caucus said in a statement. Source: [link].

Policy 52

Policy Hemp Research and Development Advocacy 52

MMJ Recs

MARCH 28, 2024

Firstly, ensure the doctor is licensed to practice medicine in Iowa and registered with the state’s Medical Cannabidiol Board. Additionally, consider reaching out to local patient advocacy groups or online forums for recommendations and insights from others who have navigated the process.

Patients 52

Patients Treatment Research and Development Therapy 52

Cannabis Law Report

JUNE 29, 2022

” “Ironically, the psychedelics Aaron is being charged with are either legal in clinical settings, scientifically proven to be beneficial medicines, decriminalized in some places or on the brink of legalization.” It’s a drag and a bummer though.” No one should be arrested or prosecuted for psychedelics, including me.”

Decriminalization 52

Decriminalization Advocacy Policy Media 52

Veriheal

JANUARY 24, 2023

With its abundance of medicinal properties and non-addictive nature, why does marijuana remain an untapped resource for researchers wanting to find treatments for debilitating chronic diseases like Parkinson’s? As a result, cannabis advocacy groups urged the agency to recognize cannabis’ medicinal value and treat it equally.

DEA 98

DEA Treatment Medicine Pets 98

Cannabis Law Report

AUGUST 8, 2022

In light of her recent passing from breast cancer, the award-winning movie star and musical hitmaker also leaves behind a legacy of medical marijuana advocacy. Medicinal cannabis is something that should be available to everyone who is going through a chronic illness or [has] pain,” she told Australian Who magazine, per The Daily Mail.

Advocacy 52

Advocacy Medicine Consumption Patients 52

Cannabis Law Report

OCTOBER 4, 2021

Congressman Earl Blumenauer (D-OR), a keynote address from Rick Doblin, PhD , founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), and two panel discussions, Psychedelics Advocacy and Expertise and Psychedelics Legislation and Regulation. Schedule (Eastern Time).

Law 52

Law Advocacy Research and Development Events 52

Veriheal

JANUARY 19, 2023

Despite cannabis remaining a Schedule I classification according to the federal Controlled Substances Act (CSA), meaning that it has no medicinal value, over 30 states in the United States have legalized it for its medicinal use. Cannabis Is Medicine—This Is Undeniable It is undeniable that cannabis has medicinal value.

Research and Development 98

Research and Development Medicine Cannabis Advocacy 98

Illinois News Joint

APRIL 10, 2023

Prior to specializing in integrative health and medical cannabis, Katie worked in primary care, oncology, women’s health, and adolescent medicine, helping people of all ages manage diverse health challenges and chronic conditions. For Consumer Cannabis Council information about membership, click here.

Therapy 76

Therapy Events Advocacy Cannabis 76

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape.

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

DECEMBER 5, 2021

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and civil society groups are backing for calls for greater transparency over emerging new cannabis guidelines. This decision legitimated the normalisation of cannabis medicines in healthcare systems. CBE write.

Research and Development 118

Research and Development Medicine Advocacy Access 118

Cannabis Law Report

MAY 16, 2022

In both instances, the state Supreme Court ruled that federal law prohibiting marijuana preempted state law, meaning the employers were not obligated to pay for the medicine.

Advocacy 52

Advocacy State Laws Legislation Law 52

Cannabis Law Report

APRIL 21, 2022

MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. We are committed to continuing to lead the field of psychedelic medicine with integrity and ethics at the core. Why work for MAPS Public Benefit Corporation (MAPS PBC)?

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. As more physicians and healthcare professionals advocate for the integration of medical marijuana into treatment plans, public trust in its medicinal value has grown.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

The Cannigma

MAY 18, 2023

In 2018, the government amended the existing legislation to allow for the cultivation, production, and distribution of cannabis for medicinal and scientific purposes. Qualified patients can access cannabis-based medicines through authorized healthcare providers, ensuring proper oversight and quality control.

Law 52

Law Cultivation Advocacy Consumption 52

Illinois News Joint

MAY 3, 2023

Prior to specializing in integrative health and medical cannabis, Katie worked in primary care, oncology, women’s health, and adolescent medicine, helping people of all ages manage diverse health challenges and chronic conditions. For Consumer Cannabis Council information about membership, click here.

Advocacy 70

Advocacy Therapy Events Conditions 70

Cannabis Law Report

NOVEMBER 2, 2021

Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts. Since NORML issued the previous edition of this report in 2017, scientists have published thousands of studies relevant to the medicinal properties of cannabis. So far this year, scientists have published over 3,600 papers.

Safety 52

Safety Patients Chronic Pain Advocacy 52